Assessing the effectiveness and cost-effectiveness of audit and feedback on physician’s prescribing indicators: study protocol of a randomized controlled trial with economic evaluation
暂无分享,去创建一个
Rassoul Dinarvand | Arash Rashidian | Mostafa Hosseini | Mohammad Abdollahi | M. Abdollahi | R. Dinarvand | A. Rashidian | M. Hosseini | Fatemeh Soleymani | Abbas Kebriaeezade | F. Soleymani | A. Kebriaeezade
[1] H. Hogerzeil,et al. Promoting rational prescribing: an international perspective. , 1995, British journal of clinical pharmacology.
[2] R. Grol,et al. Implementing guidelines and innovations in general practice: which interventions are effective? , 1998, The British journal of general practice : the journal of the Royal College of General Practitioners.
[3] Rassoul Dinarvand,et al. CHALLENGES AND ACHIEVEMENTS OF PROMOTING RATIONAL USE OF DRUGS IN IRAN , 2009 .
[4] N. Freemantle,et al. Lessons from international experience in controlling pharmaceutical expenditure. I: influencing patients , 1996, BMJ.
[5] I. Russell,et al. Intentions and statins prescribing: can the theory of planned behaviour explain physician behaviour in following guideline recommendations? , 2011, Journal of evaluation in clinical practice.
[6] J M Grimshaw,et al. Effectiveness and efficiency of guideline dissemination and implementation strategies , 2004, International Journal of Technology Assessment in Health Care.
[7] Arash Rashidian,et al. General Practitioners’ Intentions and Prescribing for Asthma: Using the Theory of Planned Behavior to Explain Guideline Implementation , 2012, International journal of preventive medicine.
[8] M. Pérez-Rodríguez,et al. Effectiveness of the Combination of Feedback and Educational Recommendations for Improving Drug Prescription in General Practice , 2004, Medical care.
[9] U. Goldbourt,et al. Are β-Blockers Efficacious as First-line Therapy for Hypertension in the Elderly?: A Systematic Review , 1998 .
[10] Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) , 1994, The Lancet.
[11] P. Macfarlane,et al. West of Scotland Coronary Prevention Study: Identification of high-risk groups and comparison with other cardiovascular intervention trials , 1996 .
[12] H. Rezazadeh,et al. Effect of interactive group discussion among physicians to promote rational prescribing. , 2009, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[13] A. Rashidian,et al. Sample size for regression analyses of theory of planned behaviour studies: case of prescribing in general practice. , 2006, British journal of health psychology.
[14] J. Slattery,et al. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. , 1994, Atherosclerosis. Supplements.
[15] I. Ajzen. The theory of planned behavior , 1991 .
[16] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. , 1995, The New England journal of medicine.
[17] Y. Behmanesh,et al. Physicians` Attitude Toward Injectable Medicines , 2006 .
[18] C. Silagy,et al. Trials of providing costing information to general practitioners: a systematic review , 1997, The Medical journal of Australia.
[19] J. Lexchin. Improving the Appropriateness of Physician Prescribing , 1998, International journal of health services : planning, administration, evaluation.
[20] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[21] Jane M. Young,et al. Audit and feedback: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.
[22] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[23] G. K. Chambers,et al. Systematic review of antihypertensive therapies: does the evidence assist in choosing a first-line drug? , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[24] N. Freemantle,et al. Fortnightly Review: Lessons from international experience in controlling pharmaceutical expenditure II: influencing doctors , 1996, BMJ.
[25] J. Grimshaw,et al. Printed educational materials: effects on professional practice and healthcare outcomes. , 2012, The Cochrane database of systematic reviews.
[26] N Freemantle,et al. Printed educational materials: effects on professional practice and health care outcomes. , 2000, The Cochrane database of systematic reviews.
[27] M. Eccles,et al. Falling on stony ground? A qualitative study of implementation of clinical guidelines' prescribing recommendations in primary care. , 2008, Health policy.
[28] S. Nikfar,et al. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran. , 2004, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.
[29] J. Cohn,et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. , 1996, The New England journal of medicine.
[30] Gholamreza-Sepehri,et al. The quality of prescribing in general practice in Kerman, Iran. , 2005, International journal of health care quality assurance incorporating Leadership in health services.
[31] R. Majdzadeh,et al. Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran , 2005, BMC international health and human rights.
[32] Elias Mossialos,et al. Pharmaceutical Expenditure in Spain: Cost and Control , 2000, International journal of health services : planning, administration, evaluation.
[33] Mohammad Abdollahi,et al. Management Information System In Promoting Rational Drug Use , 2012 .